Clinical Trial Update: A Study of LY2928057 in Hemodialysis Participants [Phase 1]

View source ↗

Summary

Phase 1 trial update for LY2928057 in adults with chronic renal insufficiency and chronic kidney disease; study completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Renal Insufficiency

Drugs mentioned

• LY2928057

Snippet

Sponsor: Eli Lilly and Company | Conditions: Renal Insufficiency, Chronic, Kidney Disease, Chronic | Phase 1 | Status: COMPLETED | Results posted: 2019-02-07